AlloVir, Inc. - Common Stock (NQ:ALVR)

9.810 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AlloVir, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

AlloVir Reports Second Quarter 2022 Financial Results

August 04, 2022

From AlloVir, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 28, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 27, 2022

Gainers

Via Benzinga

Why U.S. Stocks Are Trading Higher Ahead Of Fed Decision; Alphabet Earnings Miss Views ↗

July 27, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 250 points on Wednesday.

Via Benzinga

AlloVir's Posoleucel Shows Early Safety In Kidney Transplant Recipients ↗

June 07, 2022

Via Benzinga

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday ↗

July 28, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati...

Via Benzinga

This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

July 27, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital...

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

AlloVir Announces $126.6 Million Registered Direct Offering

July 27, 2022

From AlloVir, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients

June 07, 2022

From AlloVir, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 01, 2022

Gainers

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

AlloVir Reports First Quarter 2022 Financial Results

May 05, 2022

From AlloVir, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 27, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps Around 300 Points; AlloVir Shares Spike Higher ↗

April 20, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones climbing around 300 points on Wednesday.

Via Benzinga

Mid-Day Market Update: Nasdaq Down Over 150 Points; Netflix Shares Drop Following Earnings Report ↗

April 20, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq composite dropping more than 150 points on Wednesday.

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

28 Stocks Moving In Wednesday's Mid-Day Session ↗

April 20, 2022

Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday. AlloVir, Inc. (NASDAQ: ALVR) shares climbed 39% to $7.52...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 21, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...

Via Benzinga

Why Is AlloVir (ALVR) Stock Up 30% Today? ↗

April 20, 2022

AlloVir (ALVR) stock is taking off on Wednesday following an update from the U.S. Food and Drug Administration (FDA) on posoleucel.

Via InvestorPlace

Mid-Morning Market Update: Markets Mixed; Dow Jumps 250 Points ↗

April 20, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 250 points on Wednesday.

Via Benzinga

Why AlloVir Stock Is Surging Today ↗

April 20, 2022

AlloVir Inc (NASDAQ: ALVR) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Regenerative Medicine...

Via Benzinga

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study ↗

April 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 20, 2022

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 40.0% to $1.4 during Wednesday's pre-market session. The company's market cap stands at $39.8 million....

Via Benzinga

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients

April 20, 2022

From AlloVir

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

April 04, 2022

On Monday, 78 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: Citigroup (NYSE:C) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.